PENZBERG, Germany–Monitoring of cell viability and toxicity are critical to many areas of biological and biomedical research. This is true for understanding the molecular and biochemical pathways regulating cell viability, for developing therapeutic agents which modulate cell viability and for identifying potential cytotoxic side effects of potential therapeutic agents. Viability and cytotoxicity assays are routinely […]
LA JOLLA, Calif.–CHI-California Healthcare Institute announced today that Paul Hastings, president and chief executive officer of OncoMed Pharmaceuticals, and Ken Berger, president of the Specialty Diagnostics business for Thermo Fisher Scientific, have been elected to its board of directors. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, […]
ALAMEDA, Calif.–BioTime, Inc. (NYSE Amex: BTIM) announced earlier today that it plans to acquire ES Cell International Pte Ltd, a Singapore private limited company (“ESI”). In its press release earlier today, BioTime stated that it will “acquire all of ESI’s approximately $35 million of debt and accrued interest. ESI has no significant liabilities other than […]
Pre-mixed, Optimized Set of Markers Provides Standardization, Consistency and Simplicity BREA, Calif. — Beckman Coulter, Inc. introduces Solastra, a comprehensive CE-marked panel of conjugated-antibody cocktails for the characterization of hematolymphoid neoplasia by flow cytometry. The pre-mixed and ready-to-use panels target the appropriate markers as recommended by the 2006 Bethesda International Consensus and are compatible with […]
GOLDEN, CO– Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that it signed a contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix®, Inc., a leading firm known for its pioneering analysis of stem cells. HemoGenix® owns patented and patent-pending technology for analysis of stem cells known as the HALO® assay […]
Madison, WI — Cellular Dynamics International, Inc. (CDI), already the world’s highest volume manufacturer of human heart cells, has closed on a $40.6 million Series B private equity round. This financing enables the company to increase production capacity for its iCellTM Cardiomyocytes, human heart cells derived from induced pluripotent stem cells (iPSCs), and to launch […]
New Tool to Amplify the Power of Confocal Imaging Mannheim, Germany. High content screening is a growing discipline in life science research as the number of complex experiments is increasing and statistically relevant data become a “must” for scientific publications. Leica Microsystems has released the first High Content Screening Automation package for confocal research microscopes […]
System will be used to support antibody and recombinant protein services New Milton, Hampshire, UK — Genetix, a leading provider of solutions for imaging and image analysis, announces that Vanderbilt Monoclonal Antibody Core (VMAC), Vanderbilt University, has become the 100th facility to purchase its ClonePix™ FL system. Used for screening and selection of secretory cell […]
GIBBSTOWN, N.J.–EMD Chemicals Inc. (“EMD”) a manufacturer of high-quality inhibitors, biochemicals, antibodies, proteins and kits, announces the launch of StemSelect™ Small Molecule Regulators 384-Well Library I as part of a continuing endeavor to offer convenient and reliable products to life science researchers. “This library was developed to provide researchers with access to tools for cutting-edge […]
Expands into Stem Cell and Neuroscience Research Markets Gaithersburg, MD — Molecular Transfer Inc. (MTI), a leading developer and producer of transfection and transformation reagents, is expanding into stem cell and neuroscience research markets through the acquisition of GlobalStem. The all-cash acquisition will allow MTI to strategically bring together both companies’ technologies and expertise to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
